CLINICAL EFFICACY TRIAL - THEOPHYLLINE VS (DL) 3,7-DIHYDRO-1,8-DIMETHYL-3-(2-METHYLBUTYL)-1H-PURINE-2,6-DIONE

被引：0
|
作者：
GRASSI, C
CASALI, L
RAMPULLA, C
ROSSI, A
机构：
来源：
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS | 1980年 / 18卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：518 / 522
页数：5
相关论文
共 50 条
  • [21] Design, synthesis, and biological evaluation of 1,2,3,7-tetrahydro-6H-purin-6-one and 3,7-dihydro-1H-purine-2,6-dione derivatives as corticotropin-releasing factor, receptor antagonists
    Hartz, RA
    Nanda, KK
    Ingalls, CL
    Ahuja, VT
    Molski, TF
    Zhang, G
    Wong, H
    Peng, Y
    Kelley, M
    Lodge, NJ
    Zaczek, R
    Gilligan, PJ
    Trainor, GL
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (19) : 4741 - 4754
  • [22] WY-49,051, 7-[3-[4-(DIPHENYLMETHOXY)-1-PIPERIDINYL]PROPYL]-3,7-DIHYDRO-1,3-DIMETHYL-1H-PURINE-2-6-DIONE, A NOVEL AGENT WITH ANTIHISTAMINE PROPERTIES
    NIELSEN, ST
    BURNS, L
    DOVE, P
    BUONATO, C
    WEBB, M
    HAND, J
    CHANG, J
    ABOUGHARBIA, M
    FASEB JOURNAL, 1988, 2 (05): : A1405 - A1405
  • [23] Crystal structure of 1H-purine-2,6-dione-3,7-dihydro-3-me thyl-1$ MIN@(5-oxohexyl)-7-propyl, C15H22N4O3
    Koman, M.
    Veverka, M.
    Miklos, D.
    Zeitschrift fuer Kristallographie, 210 (11):
  • [24] Corticotropin releasing factor-1 receptor antagonists: Synthesis and structure-activity relationships of 1,2,3,7-tetrahydro-6H-purin-6-one and 3,7-dihydro-1H-purine-2,6-dione derivatives.
    Hartz, RA
    Nanda, KK
    Ingalls, CL
    Ahuja, VT
    Molski, TF
    Mattson, GK
    Zhang, G
    Wong, H
    Zaczek, R
    Trainor, GL
    Gilligan, PJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U62 - U62
  • [25] MOLECULAR DOCKING STUDY ON 1-(3-(4-BENZYLPIPERAZIN-1-YL)PROPYL)-3,7-DIMETHYL-1H-PURINE-2,6(3H,7H)-DIONE AS AN ACETYLCHOLINESTERASE INHIBITOR
    Hristova, Maria
    Atanasova, Mariyana
    Valkova, Iva
    Andonova, Lilya
    Doytchinova, Irini
    Zlatkov, Alexander
    CBU INTERNATIONAL CONFERENCE PROCEEDINGS 2018: INNOVATIONS IN SCIENCE AND EDUCATION, 2018, 6 : 898 - 903
  • [26] STRUCTURES OF BINUCLEAR COPPER(II) CHLOROACETATE COMPLEXES - TETRAKIS-(MU-MONOCHLOROACETATO-O,O')-BIS[(3,7-DIHYDRO-1,3,7-TRIMETHYL-1H-PURINE-2,6-DIONE)COPPER(II)], [CU2(C2H2CLO2)4(C8H10N4O2)2]
    KOREN, B
    VALACH, F
    SIVY, P
    MELNIK, M
    ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY, 1985, 41 (AUG): : 1160 - 1162
  • [27] Synthesis and cardiovascular activity of new 8-alkylamino-1,3-dimethyl-7-(2-hydroxy-3-piperazinopropyl)-3,7-dihydro-1H-purine-2,6-diones
    Chlon-Rzepa, G
    Pawlowski, M
    Zygmunt, M
    Filipek, B
    Maciag, D
    POLISH JOURNAL OF PHARMACOLOGY, 2004, 56 (06): : 755 - 766
  • [28] 8-(2-Hydroxyphenyl)-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione
    Booysen, Irvin
    Hlela, Thulani
    Ismail, Muhammed
    Gerber, Thomas
    Hosten, Eric
    Betz, Richard
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : O2347 - U374
  • [29] 8-Chloro-7-(2,6-dichlorobenzyl)-1,3-dimethyl-7H-purine-2,6(1H,3H)-dione
    Belyakov, S
    Alksnis, E
    Muravenko, V
    Lukevics, E
    ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY, 2005, 61 : O63 - O64
  • [30] Benzene-1,2,4,5-tetracarboxylicacidbis(1,3,7-trimethyl- 2,3,6,7-tetrahydro1H- purine-2,6-dione)
    Arman, Hadi D.
    Tiekink, Edward R. T.
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2013, 69 : O1443 - +
12345